K. Plouffe

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.

S. Tomlins, S. Kaffenberger, T. Morgan, 2019, JCO precision oncology.

Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series

S. Dhanasekaran, A. Chinnaiyan, R. Mehra, 2019, Medical Oncology.

Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas

N. Palanisamy, S. Tomlins, R. Nazarian, 2019, Modern Pathology.

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Nickolay A. Khazanov, M. Burkard, D. Rhodes, 2023, Communications Medicine.

Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study.

P. Boonstra, S. Tomlins, A. Sisk, 2020, European urology.

Transcriptomic heterogeneity in multifocal prostate cancer.

M. Rubin, A. Chinnaiyan, N. Rioux-Leclercq, 2018, JCI insight.

TP53 Mutations and CDKN2A Mutations/Deletions are Highly Recurrent Molecular Alterations in the Malignant Progression of Sinonasal Papillomas

S. Tomlins, R. Seethala, T. Carey, 2020, Modern Pathology.

Highly Recurrent IDH1 Mutations in Prostate Cancer with Psammomatous Calcification (PCWPC).

A. Chinnaiyan, S. Tomlins, R. Mehra, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Transcriptomic heterogeneity in multifocal prostate cancer.

M. Rubin, A. Chinnaiyan, N. Rioux-Leclercq, 2018, JCI insight.